摘要
近年来,中医药在抗骨质疏松症方面显示出独特优势。龟板被证实可通过miRNA及其靶基因、信号通路及相关因子调控BMSCs功能,从而抗骨质疏松症。本文对龟板调控BMSCs增殖、迁移和成骨分化及其抗骨质疏松症的研究进展进行综述,发现龟板体外可通过调节BMP-4、VDR、RARα、Id1等表达调控BMSCs增殖;可上调HGF/c-met轴、SDF-1/CXCR4轴促进BMSCs迁移;可通过调节成骨相关因子、miRNAs和信号通路调控BMSCs成骨分化。此外,龟板体内可有效抗PMOP、GIOP和SOP。本文旨在为中医药防治骨质疏松症提供相关参考。
Recently,traditional Chinese medicine has shown unique advantages in anti-osteoporosis.Plastrum testudinis(PT)has been shown to affect the function of BMSCs through regulating osteoblast-related miRNAs’target genes,signaling pathways and related-factors,thereby achieving anti-osteoporosis effect.In this paper,we reviewed the effects of PT on the proliferation,migration,and osteogenic differentiation of BMSCs and its mechanism on anti-osteoporosis,providing references for anti-osteoporosis in traditional Chinese medicine.It have been found that PT can regulate BMSCs’proliferation through BMP-4,VDR,RARαand Id1 in vitro.PT can up-regulate the axis of HGF/c-met and SDF-1/CXCR4 to promote the migration of BMSCs.PT can regulate BMSCs’osteogenic differentiation through osteoblast-related factors,miRNAs and signaling pathways.In addition,PT can effectively resist PMOP,GIOP and SOP in vivo.This will provide references for anti-osteoporosis using traditional Chinese medicine.
作者
余翔
任辉
沈耿杨
张鹏
余富勇
尚奇
汤凯
张志达
招文华
梁德
江晓兵
YU Xiang;REN Hui;SHEN Gengyang;ZHANG Peng;YU Fuyong;SHANG Qi;TANG Kai;ZHANG Zhida;ZHAO Wenhua;LIANG De;JIANG Xiaobing(Department of Spinal Surgery, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China;Guangzhou University of Chinese Medicine, Guangzhou 510405, China;Lingnan Medical Research Center of Guangzhou Univercity of Chinese Medicine, Guangzhou 510405, China)
出处
《中国骨质疏松杂志》
CAS
CSCD
北大核心
2020年第12期1847-1851,共5页
Chinese Journal of Osteoporosis
基金
国家自然科学基金项目(81904225)
广东省自然科学基金项目(2018A030310615)
广东省教育厅基础研究及应用基础研究项目(2018KZDXM021)
广州中医药大学第一临床医学院优秀博士论文培育项目(YB201702)。
关键词
中医药
龟板
骨质疏松症
干细胞
综述
traditional Chinese medicine
plastrum testudinis
osteoporosis
stem cells
review